Electroretinography

DIAGNOSTIC_TEST4 trials

Sponsors

Central Hospital, Nancy, France, NHS Greater Glasgow and Clyde, Diopsys, Inc., Centre Psychothérapique de Nancy

Conditions

Cannabis UseDark-adapted ERGEarly PsychosisRetinal DiseaseSchizophrenia Prodromal

Unknown Phase

Electrophysiological Study of the Functioning of Magnocellular Visual Pathway in Regular Cannabis Users

CompletedNCT02864680

Central Hospital, Nancy, FranceCannabis Use

Start: 2014-02-28End: 2019-06-30Updated: 2021-04-29

Electroretinography: Investigation of a Protocol Change

NHS Greater Glasgow and ClydeDark-adapted ERG

Start: 2017-10-31End: 2018-02-28Target: 262Updated: 2017-09-07

Study to Compare the Diopsys NOVA and LKC RETeval Devices

CompletedNCT05416268

Diopsys, Inc.Retinal Disease

Start: 2022-05-04End: 2022-05-06Updated: 2022-06-14

Perception and Integration of Sensory Information in the Early Stages of Psychosis

Not yet recruitingNCT07446569

Centre Psychothérapique de NancyEarly Psychosis, Schizophrenia Prodromal

Start: 2026-04-01End: 2028-11-01Target: 294Updated: 2026-03-03

Related Papers

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

Frontiers in Psychiatry2025-04-25

Association between retinal and cortical visual electrophysiological impairments in schizophrenia

Journal of Psychiatry and Neuroscience2023-05-197 citations

Impaired P100 among regular cannabis users in response to magnocellular biased visual stimuli.

2021-09-114 citations